HCLS1 associated protein X-1 enhances tongue squamous cell carcinoma burden by driving K835 L-lactylation of DEAD-box helicase 24

L-lactylation converts tumor metabolic byproducts into global commanders that drive metabolic reprogramming, drug resistance, and immune evasion. However, the epigenetic mechanism underlying L-lactylation in tongue squamous cell carcinoma (TSCC) remains unidentified. This study employed modified proteomics and bioinformatics to identify mechanisms related to L-lactylation in the TSCC progression. HAX1 knockout and stable overexpression cell lines were established using CRISPR/Cas9 and lentivirus. Subsequently, the effects of L-lactylation mediated by the HAX1/DDX24 axis on TSCC burden were investigated in vivo and in vitro through rescue experiments. We found that HAX1 was consistently identified as a prognostic risk target across four TSCC-related datasets GSE143950, GSE149008, GSE156178, TCGA-OSCC, showing high expression in TSCC tissues and increasing with stage. HAX1 −/− effectively restricted the growth, metastasis, glycolysis and tumor burden of Cal27 and SCC4 cells, while its overexpression exhibited the opposite regulatory pattern. In post-translational modification analysis, HAX1 −/− downregulated the levels of acetylation, β-hydroxybutyrylation, L-lactyllysine, and succinylation, and upregulated crotonylation, particularly of L-lactyllysine. L-lactylation proteomics confirmed that DDX24 was a downstream target associated with HAX1-mediated L-lactylation, and its prognostic value and expression pattern were similar to those of HAX1. Moreover, HAX1 and lactate effectively upregulated DDX24 K835 L-lactylation in TSCC cells. Importantly, DDX24 knockdown restricts HAX1-mediated malignant phenotypes, whereas DDX24 overexpression had the opposite effect. In conclusion, HAX1 is an independent risk factor for TSCC progression and contributes to tumor burden by driving DDX24 K835 L-lactylation. This discovery holds promise for driving the development of new strategies targeting epigenetic and metabolic reprogramming in TSCC.

Authors

Institutions

Publication Details

Journal
Cell Communication and Signaling
Published
2026-11-21
DOI
https://doi.org/10.1186/s12964-026-03371-4
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

HCLS1 associated protein X-1 enhances tongue squamous cell carcinoma burden by driving K835 L-lactylation of DEAD-box helicase 24

Hui Guo, Zhou Heng-min, Peiqi Hao, Jin-song Pan et al.
3 links
Cell Communication and Signaling
Cancer, Hypoxia, and Metabolism
article

HCLS1 associated protein X-1 enhances tongue squamous cell carcinoma burden by driving K835 L-lactylation of DEAD-box helicase 24

Hui Guo, Zhou Heng-min, Peiqi Hao, Jin-song Pan, Yang Liu, Xin-yu Zhang, Xing Xu
article en

Abstract

L-lactylation converts tumor metabolic byproducts into global commanders that drive metabolic reprogramming, drug resistance, and immune evasion. However, the epigenetic mechanism underlying L-lactylation in tongue squamous cell carcinoma (TSCC) remains unidentified. This study employed modified proteomics and bioinformatics to identify mechanisms related to L-lactylation in the TSCC progression. HAX1 knockout and stable overexpression cell lines were established using CRISPR/Cas9 and lentivirus. Subsequently, the effects of L-lactylation mediated by the HAX1/DDX24 axis on TSCC burden were investigated in vivo and in vitro through rescue experiments. We found that HAX1 was consistently identified as a prognostic risk target across four TSCC-related datasets GSE143950, GSE149008, GSE156178, TCGA-OSCC, showing high expression in TSCC tissues and increasing with stage. HAX1 −/− effectively restricted the growth, metastasis, glycolysis and tumor burden of Cal27 and SCC4 cells, while its overexpression exhibited the opposite regulatory pattern. In post-translational modification analysis, HAX1 −/− downregulated the levels of acetylation, β-hydroxybutyrylation, L-lactyllysine, and succinylation, and upregulated crotonylation, particularly of L-lactyllysine. L-lactylation proteomics confirmed that DDX24 was a downstream target associated with HAX1-mediated L-lactylation, and its prognostic value and expression pattern were similar to those of HAX1. Moreover, HAX1 and lactate effectively upregulated DDX24 K835 L-lactylation in TSCC cells. Importantly, DDX24 knockdown restricts HAX1-mediated malignant phenotypes, whereas DDX24 overexpression had the opposite effect. In conclusion, HAX1 is an independent risk factor for TSCC progression and contributes to tumor burden by driving DDX24 K835 L-lactylation. This discovery holds promise for driving the development of new strategies targeting epigenetic and metabolic reprogramming in TSCC.

Cell Communication and Signaling
Kunming University of Science and Technology (CN), Ruijin Hospital (CN), First People's Hospital of Yunnan Province (CN)
National Natural Science Foundation of China
Good health and well-being
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon